Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
26 participants
INTERVENTIONAL
2011-10-31
2017-04-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sleep Restriction and Obesity
NCT01580761
Cardiovascular Effects of Partial Sleep Deprivation
NCT00669513
Effect of Total Sleep Deprivation on Vascular Function
NCT04535219
Impact of Sleep Restriction in Women
NCT02835261
The Effects of Sleep Deprivation on Physiological and Perceptual Responses During Exercise
NCT05313932
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
sleep restriction
restricted sleep during the experimental period
sleep restriction
restricted sleep
normal sleep
normal sleep during the experimental period
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
sleep restriction
restricted sleep
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No chronic medical conditions other than seasonal or environmental allergies
* On no prescription medications other than second generation antihistamines (Cetirizine, Fexofenadine, Desloratadine, Loratadine, etc), oral contraceptive pills, or intrauterine devices.
* BMI 18.5-35 kg/m2
* Both normotensive and prehypertensive people are eligible and will be studied
* Not a current smoker or tobacco user
* Not pregnant or breast feeding and not intending to become pregnant or breast feed
Exclusion Criteria
* History of anxiety or depression, and those taking any medications other than non-sedating antihistamines or oral contraceptives.
* Those found to have depression on a depression screening tool (BDI-II) will be excluded. Current smokers will be excluded.
* All female subjects will undergoing a screening pregnancy test and excluded if positive.
* Subjects found to have significant sleep disorders will be excluded.
18 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mayo Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Virend Somers, MD, PhD
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Virend K Somers, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Mayo Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mayo Clinic
Rochester, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Mayo Clinic Clinical Trials
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
11-002121
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.